Time to Test Effects of CBD in Cardiovascular Disease?

Well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease are needed, based on evidence from preclinical studies showing that it has anti-inflammatory effects, a new report suggests. The systematic review of nine preclinical studies found reproducible positive adverse outcomes in vivo models with CBD. Mechanisms for the findings included … Read more

Cannabis for Pain Linked to Slight Risk for Arrhythmia

Patients who received a first prescription for medicinal cannabis for chronic pain were more likely to have new onset of arrhythmia — bradyarrhythmia, tachyarrhythmia, or a conduction disorder — within 6 months than were similar nonusers, in a new case-control study. There were no between-group differences in the incidence of heart failure or acute coronary … Read more

The Anxious Patient Needs Psychosomatic Primary Care

A balance between fear and relaxation is normal. However, mental dispositions and the continuous influence of environmental stimuli can disrupt this balance. A failure in therapy can often conceal unvoiced fears. This article is based on the lecture “State of the Art: Treating Anxiety Disorders” by Christian Albus, MD, director of the Clinic and Polyclinic … Read more

Patients With Heart Failure May Need Psychological Treatment

Depression and other psychosocial risk factors can foster the onset of heart failure and exacerbate its course. The significance of this connection is often underestimated, however. A position paper by the European Association of Preventive Cardiology therefore recommends that psychosocial risk factors be more integrated into the treatment of patients with chronic heart failure. “Patients … Read more

Exercise Provides Twice the CV Benefit in Anxiety, Depression

Meeting guideline-recommended exercise targets is associated with a reduced risk of cardiovascular disease (CVD) in everyone, but the benefits may be particularly clear for people with anxiety and depression, a new analysis suggests. In a study of more than 50,000 adult patients with or without CVD or risk factors who were followed for a median … Read more